Pilot Study: Combining Formal and Peer Education with FibroScan to Increase HCV Screening and Treatment in Persons who use Drugs

Journal of Substance Abuse Treatment

Volumn 67, Issue , 2016, Pages 44-49

  Arain, Amber ^a,b   De Sousa, Jessica ^b   Corten, Kirsten ^b   Verrando, Rita ^c   Thijs, Herbert ^b   Mathei, Catharina ^d,e   Buntinx, Frank ^f   Robaeys, Geert ^a,b,g  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c Medisch Sociaal Opvang Centrum   (Belgium)

^d Free Clinic   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Hepatitis C virus; Knowledge; Persons who use drugs; Therapeutic education

Indexed keywords

OPIATE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; ELASTOGRAPH; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE SUBSTITUTION TREATMENT; PERSON WHO USE DRUG; PILOT STUDY; PRIORITY JOURNAL; SCREENING; ATTITUDE TO HEALTH; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; PEER GROUP; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION; SINGLE BLIND PROCEDURE; SUBSTANCE ABUSE; TIME FACTOR;

ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PEER GROUP; PILOT PROJECTS; SINGLE-BLIND METHOD; SUBSTANCE ABUSE, INTRAVENOUS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84969716693     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2016.04.001     Document Type: Article

References (33)

1. Afdhal N.H., Bacon B.R., Patel K., Lawitz E.J., Gordon S.C., Nelson D.R., McHutchison J.G. Accuracy of FibroScan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: A US multi-center study. Clinical Gastroenterology and Hepatology 2014.
2. Beste L.A., Straits-Troster K., Zickmund S., Larson M., Chapko M., Dominitz J.A. Specialty care and education associated with greater disease-specific knowledge but not satisfaction with care for chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2009, 30:275-282.
3. Cacoub P., Ouzan D., Melin P., Lang J.P., Rotily M., Fontanges T., Marcellin P. Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study. World Journal of Gastroenterology 2008, 14:6195-6203.
4. Denniston M.M., Klevens R.M., McQuillan G.M., Jiles R.B. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology 2012, 55:1652-1661.
5. Doab A., Treloar C., Dore G.J. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clinical Infectious Diseases 2005, 40(Suppl. 5):S313-S320.
6. Edlin B.R., Kresina T.F., Raymond D.B., Carden M.R., Gourevitch M.N., Rich J.D., Cargill V.A. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases 2005, 40(Suppl. 5):S276-S285.
7. Foucher J., Reiller B., Jullien V., Leal F., di Cesare E.S., Merrouche W., de Ledinghen V. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: A prospective study. Journal of Viral Hepatitis 2009, 16:121-131.
8. Fusfeld L., Aggarwal J., Dougher C., Vera-Llonch M., Bubb S., Donepudi M., Goss T.F. Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection. BMC Infectious Diseases 2013, 13:234.
9. Geibel S., King'ola N., Temmerman M., Luchters S. The impact of peer outreach on HIV knowledge and prevention behaviours of male sex workers in Mombasa, Kenya. Sexually Transmitted Infections 2012, 88:357-362.
10. Grebely J., Dore G.J. What is killing people with hepatitis C virus infection?. Seminars in Liver Disease 2011, 31:331-339.
11. Grebely J., Genoway K.A., Raffa J.D., Dhadwal G., Rajan T., Showler G., Fischer B. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug and Alcohol Dependence 2008, 93:141-147.
12. Grebely J., Knight E., Genoway K.A., Viljoen M., Khara M., Elliott D., Conway B. Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: A novel model incorporating multidisciplinary care and peer support. European Journal of Gastroenterology & Hepatology 2010, 22:270-277.
13. Gupta K., Romney D., Briggs M., Benker K. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals. Journal of Community Health 2007, 32:221-230.
14. Larrey D., Salse A., Ribard D., Boutet O., Hyrailles-Blanc V., Niang B., Daures J.P. Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-alpha2a and ribavirin. Clinical Gastroenterology and Hepatology 2011, 9:781-785.
15. Lubega S., Agbim U., Surjadi M., Mahoney M., Khalili M. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver International 2013, 33:999-1007.
16. Mateu-Gelabert P., Gwadz M.V., Guarino H., Sandoval M., Cleland C.M., Jordan A., Friedman S.R. The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection. AIDS Education and Prevention 2014, 26:144-157.
17. Mehta S.H., Genberg B.L., Astemborski J., Kavasery R., Kirk G.D., Vlahov D., Thomas D.L. Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health 2008, 33:126-133.
18. Moessner B.K., Jorgensen T.R., Skamling M., Vyberg M., Junker P., Pedersen C., Christensen P.B. Outreach screening of drug users for cirrhosis with transient elastography. Addiction 2011, 106:970-976.
19. Nyamathi A., Tyler D., Sinha K., Marfisee M., Cohen A., Greengold B. Predictors of hepatitis knowledge improvement among methadone maintained clients enrolled in a hepatitis intervention program. Journal of Community Health 2010, 35:423-432.
20. Proeschold-Bell R.J., Hoeppner B., Taylor B., Cohen S., Blouin R., Stringfield B., Muir A.J. An interrupted time series evaluation of a hepatitis C intervention for persons with HIV. AIDS and Behavior 2011, 15:1721-1731.
21. Robaeys G., Grebely J., Mauss S., Bruggmann P., Moussalli J., De Gottardi A., Dore G.J. Recommendations for the management of hepatitis C virus infection among people who inject drugs. Clinical Infectious Diseases 2013, 57(Suppl. 2):S129-S137.
22. Roose R.J., Cockerham-Colas L., Soloway I., Batchelder A., Litwin A.H. Reducing barriers to hepatitis C treatment among drug users: An integrated hepatitis C peer education and support program. Journal of Health Care for the Poor and Underserved 2014, 25:652-662.
23. Shah H.A., Abu-Amara M. Education provides significant benefits to patients with hepatitis B virus or hepatitis C virus infection: A systematic review. Clinical Gastroenterology and Hepatology 2013, 11:922-933.
24. Skipper C., Guy J.M., Parkes J., Roderick P., Rosenberg W.M. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: Implications for the national strategy. Gut 2003, 52:1500-1504.
25. Solomon S.S., Mehta S.H., Srikrishnan A.K., Solomon S., McFall A.M., Laeyendecker O., Quinn T.C. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: A cross-sectional study. The Lancet Infectious Diseases 2015, 15:36-45.
26. Surjadi M., Torruellas C., Ayala C., Yee H.F., Khalili M. Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Digestive Diseases and Sciences 2011, 56:213-219.
27. Swan D., Long J., Carr O., Flanagan J., Irish H., Keating S., Cullen W. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration. AIDS Patient Care and STDs 2010, 24:753-762.
28. Ti L., Kaplan K., Hayashi K., Suwannawong P., Wood E., Kerr T. Low rates of hepatitis C testing among people who inject drugs in Thailand: implications for peer-based interventions. Journal of Public Health (Oxford, England) 2013, 35:578-584.
29. Treloar C., Hull P., Bryant J., Hopwood M., Grebely J., Lavis Y. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs. Drug and Alcohol Dependence 2011, 116:52-56.
30. Treloar C., Hull P., Dore G.J., Grebely J. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug and Alcohol Review 2012, 31:918-924.
31. Treloar C., Newland J., Rance J., Hopwood M. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: Perceptions of clients and health professionals. Journal of Viral Hepatitis 2010, 17:839-844.
32. Treloar C., Rance J., Dore G.J., Grebely J., Group, E.S Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study. Journal of Viral Hepatitis 2014, 21:560-567.
33. Zeremski M., Dimova R.B., Zavala R., Kritz S., Lin M., Smith B.D., Talal A.H. Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance. Journal of Addictions Medicine 2014, 8:249-257.